Page 80 - Read Online
P. 80

Santos et al. Vessel Plus 2021;5:21  https://dx.doi.org/10.20517/2574-1209.2020.69  Page 15 of 16

                   SAMINOR Study. BMJ Open 2019;9:e028939.  DOI  PubMed  PMC
               39.      Sacco RL, Benjamin EJ, Broderick JP, et al. Risk Factors. Stroke 1997;28:1507-17.  DOI  PubMed
               40.      Kilkenny M, Harris D, Ritchie E, Price C, Cadilhac D. Hospital management and outcomes of stroke in Indigenous Australians:
                   evidence from the 2009 Acute Care National Stroke Audit. Int J Stroke 2013;8:164-171.  DOI  PubMed
               41.      Dos Santos A, Mohr K, Jude M, et al. A prospective analysis of stroke recognition, stroke risk factors, thrombolysis rates and
                   outcomes in Indigenous Australians from a large rural referral hospital. Intern Med J 2020.  DOI  PubMed
               42.      Tiedeman C, Suthers B, Julien B, Hackett A, Oakley P. Management of stroke in the Australian Indigenous population: From hospitals
                   to communities. Intern Med J 2019;49:962-8.  DOI  PubMed
               43.      Gardiner FW, Bishop L, Dos Santos A, et al. Aeromedical retrieval for stroke in Australia. Cerebrovasc Dis 2020;49:334-40.  DOI
                   PubMed
               44.      Nakagawa K, Koenig MA, Asai SM, Chang CW, Seto TB. Disparities among Asians and Native Hawaiians and Pacific Islanders with
                   ischemic stroke. Neurology 2013;80:839-43.  DOI  PubMed  PMC
               45.      Churchwell K, Elkind M, Benjamin R, Carson A, Change E, Lawrence W. Call to action: Structural Racism as a fundamental driver of
                   health disparities: A presidential advisory from the American Heart Association. Circulation 2020;142:454-68.  DOI  PubMed
               46.      Nakagawa K, Koenig MA, Seto TB, Asai SM, Chang CW. Racial Disparities among Native Hawaiians and Pacific Islanders with
                   intracerebral hemorrhage. Neurology 2012;79:675-80.  DOI  PubMed  PMC
               47.      Nakagawa K, MacDonald PR, Asai SM. Stroke Disparities: Disaggregating Native Hawaiians from other Pacific Islanders. Ethn Dis
                   2015;25:157-61.  PubMed  PMC
               48.      Akpalu A, Sarfo FS, Ovbiagele B, et al. Phenotyping Stroke in Sub-Saharan Africa: Stroke Investigative Research and Education
                   Network (SIREN) Phenomics Protocol. Neuroepidemiology 2015;45:73-82.  DOI  PubMed  PMC
               49.      Howard VJ, Cushman M, Pulley L, et al. The reasons for geographic and racial differences in stroke study: objectives and design.
                   Neuroepidemiology 2005;25:135-43.  DOI  PubMed
               50.      Soto A, Morales G, Provoste R, et al. Association between Mapuche Ethnicity and Stroke: A Case-Control Study. J Stroke
                   Cerebrovasc Dis 2019;28:1311-6.  DOI  PubMed
               51.      Del Brutto OH, Mera RM, Montalvan M, et al. Cardiovascular health status and metabolic syndrome in Ecuadorian Natives/Mestizos
                   aged 40 years or more with and without stroke and ischaemic heart disease - An Atahualpa Project Case-Control Nested Study. J
                   Stroke Cerebrovasc Dis 2014;23:643-8.  DOI  PubMed
               52.      He VY, Condon JR, You J, Zhoa Y, Burrow JN. Adverse outcome after incident stroke hospitalisation for Indigenous and non-
                   Indigenous Australians in the Northern Territory. Int J Stroke 2015;10:89-95.  DOI  PubMed
               53.      McGorrian C, Yusuf S, Islam S, et al. Estimating modifiable coronary heart disease risk in multiple regions of the world: the
                   INTERHEART Modifiable Risk Score. Eur Heart J 2011;32:581-89.  DOI  PubMed
               54.      Siri SRA, Braaten T, Jacobsen BK, Melhus M, Eliassen BM. Distribution of risk factors for cardiovascular disease and the estimated
                   10-year risk of acute myocardial infarction or cerebral stroke in Sami and non-Sami populations: The SAMINOR-2 Clinical survey.
                   Scand J Public Health 2018;46:638-46.  DOI  PubMed  PMC
               55.      Nystad T, Utsi E, Selmer R, et al. Distribution of apoB/apoA-1 ratio and blood lipids in Sami, Kven and Norwegian populations: the
                   SAMINOR study. Int J Circumpolar Health 2008;67:67-81.  PubMed
               56.      Selmer R, Igland J, Ariansen I, et al. NORRISK 2: A Norwegian risk model for acute cerebral stroke and myocardial infarction. Eur J
                   Prev Cardiol 2017;24:773-82.  DOI  PubMed
               57.      Hung KH, Liou KC, Hsu KN, Hu C. Disparities in Ischaemic Stroke Subtypes and Risk Factors between Taiwanese Aborigines and
                   Han Chinese in Taitung, Taiwan. Int J Gerontol 2016;10:17-21.  DOI
               58.      Langhorne P, Williams BO, Gilchrist W, Howie K. Do stroke units save lives? Lancet 1993;342:395-8.  DOI  PubMed
               59.      Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis
                   with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014;384:1929-35.
                   DOI  PubMed  PMC
               60.      Parsons M, Spratt N, Bivard A, et al. A randomised trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med
                   2012;366:1099-107.  DOI  PubMed
               61.      Goyal M, Menon BK, Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual
                   patient data from five randomised trials. Lancet 2016;387:1723-31.  DOI  PubMed
               62.      Kapral MK, Shah BR, Green ME, et al. Hospital admission for stroke or transient ischemic attack among First Nations people with
                   diabetes in Ontario: a population-based cohort study. CMAJ Open 2020;8:156-62.  DOI  PubMed  PMC
               63.      Attenello FJ, Adamczyk P, Wen G, et al. Racial and socioeconomic disparities in access to mechanical revascularisation procedures for
                   acute ischemic stroke. J Stroke Cerebrovasc Dis 2014;23:327-34.  DOI  PubMed  PMC
               64.      Kimball M, Neal D, Waters M, Hoh BL. Race and income disparities in ischemic stroke care: Nationwide inpatient sample database,
                   2002 to 2008. J Stroke Cerebrovasc Dis 2014;23:17-24.  DOI  PubMed
               65.      Hsia AW, Edwards DF, Morgenstern LB, et al. Racial disparities in tissue plasminogen activator treatment rate for stroke. A
                   Population-Based Study. Stroke 2011;42:2217-21.  DOI  PubMed  PMC
               66.      Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Treatment with tissue plasminogen activator and inpatient mortality rates for
                   patients with ischaemic stroke treated in community hospitals. Stroke 2001;32:1832-40.  DOI  PubMed
               67.      Johnson SC, Fung LH, Gillum LA, et al. Utilisation of intravenous tissue-type plasminogen activator for ischemic stroke at academic
                   medical centers: the influence of ethnicity: editorial comment: it is time to implement stroke practice improvement programs and
                   prevent the racial disparity in stroke care. Stroke 2001;32:1061-8.  DOI  PubMed
   75   76   77   78   79   80   81   82   83   84   85